Fast Acting freedom: Intranasal Etripamil for sudden Paroxysmal Supraventricular Tachycardia

Patients with arrhythmias, such as Paroxysmal Supraventricular Tachycardia (PSVT), face a higher risk of heart-related issues and complications.PSVT can lead to symptoms like light-headedness, chest pain, anxiety, and shortness of breath due to the rapid heartbeat.To manage these symptoms, patients are typically prescribed oral medications to regulate heart rate and maintain normal rhythm.There is, however, a need for an effective PSVT treatment that is well-tolerated and can be self-administered with a rapid onset.Etripamil, a fast-acting L-type calcium channel blocker, is a non-dihydropyridine medication formulated as an intranasal spray to quickly terminate AV nodal-dependent PSVT episodes in situations where medical supervision is not available.